References
- Andersen K. W., Mouridsen H. T., Castberg T., et al. Organization of the Danish adjuvant trials in breast cancer. Dan. Med. Bull. 1981; 28: 102
- Brincker H. Distant recurrence in breast cancer. Survival expectations and first choice of chemotherapy regimen. Acta Oncol. 1988; 27: 729
- Carstensen B., Storm H. H. Overlevelseskurver fra Cancerregistret 1948–82. Personal communication 1987
- Cuzick J., Stewart H., Peto R., et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat. Rep. 1987; 71: 15
- Cuzick J., Stewart H., Peto R., et al. Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. Cancer Treat. Rep. 1987; 71: 7
- Dombernowsky P., Brincker H., Hansen M., et al. Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B. Acta Oncol. 1988; 27: 691
- Early Breast Cancer Triallist Collaborative Group. The effect of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 70 randomized trials among 30000 women. New Engl. J. Med. 1988, (in press)
- Ewertz M., Carstensen B. Trends in breast cancer incidence and mortality in Denmark 1943–1982. Int. J. Cancer 1988; 41: 46
- Fischer B., Redmoud C., Fischer E. R. Clinical trials and the surgical treatment of breast cancer. Surg. Clin. North Am. 1978; 58: 723
- Mouridsen H. T., Rose C., Overgaard M., et al. Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant studies DBCG 77C and 82C. Acta Oncol. 1988; 27: 699
- Thomsen H. S., Lund J. O., Munck O., Rossing N. The value of pre-scheduled bone scintigraphies in breast cancer. Acta Oncol. 1988; 27: 617
- Winkel P. The Danish Breast Cancer Group (DBCG) biochemical tumor marker program. Acta Oncol. 1988; 27: 611